S.C. Ropharma S.A. (BVB:RPH)

S.C. Ropharma Statistics

Total Valuation

S.C. Ropharma has a market cap or net worth of RON 88.96 million. The enterprise value is 250.54 million.

Market Cap	88.96M
Enterprise Value	250.54M

Important Dates

The next estimated earnings date is Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

S.C. Ropharma has 511.27 million shares outstanding.

Current Share Class	511.27M
Shares Outstanding	511.27M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+1.82%
Owned by Insiders (%)	14.07%
Owned by Institutions (%)	8.61%
Float	177.64M

Valuation Ratios

The trailing PE ratio is 322.27.

PE Ratio	322.27
Forward PE	n/a
PS Ratio	0.06
PB Ratio	0.34
P/TBV Ratio	0.50
P/FCF Ratio	5.13
P/OCF Ratio	2.91
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.19, with an EV/FCF ratio of 14.46.

EV / Earnings	907.61
EV / Sales	0.18
EV / EBITDA	5.19
EV / EBIT	10.52
EV / FCF	14.46

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.64.

Current Ratio	1.05
Quick Ratio	0.63
Debt / Equity	0.64
Debt / EBITDA	3.48
Debt / FCF	9.68
Interest Coverage	4.50

Financial Efficiency

Return on equity (ROE) is 3.02% and return on invested capital (ROIC) is 3.51%.

Return on Equity (ROE)	3.02%
Return on Assets (ROA)	1.60%
Return on Invested Capital (ROIC)	3.51%
Return on Capital Employed (ROCE)	6.25%
Revenue Per Employee	1.16M
Profits Per Employee	224
Employee Count	1,723
Asset Turnover	1.54
Inventory Turnover	5.18

Taxes

In the past 12 months, S.C. Ropharma has paid 14.47 million in taxes.

Income Tax	14.47M
Effective Tax Rate	65.12%

Stock Price Statistics

The stock price has decreased by -2.25% in the last 52 weeks. The beta is 0.31, so S.C. Ropharma's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	-2.25%
50-Day Moving Average	0.17
200-Day Moving Average	0.16
Relative Strength Index (RSI)	52.86
Average Volume (20 Days)	57,485

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, S.C. Ropharma had revenue of RON 1.43 billion and earned 276,041 in profits. Earnings per share was 0.00.

Revenue	1.43B
Gross Profit	309.59M
Operating Income	23.83M
Pretax Income	22.22M
Net Income	276,041
EBITDA	36.02M
EBIT	23.83M
Earnings Per Share (EPS)	0.00

Balance Sheet

The company has 23.15 million in cash and 167.83 million in debt, giving a net cash position of -144.68 million or -0.28 per share.

Cash & Cash Equivalents	23.15M
Total Debt	167.83M
Net Cash	-144.68M
Net Cash Per Share	-0.28
Equity (Book Value)	260.72M
Book Value Per Share	0.48
Working Capital	28.90M

Cash Flow

In the last 12 months, operating cash flow was 30.59 million and capital expenditures -13.26 million, giving a free cash flow of 17.33 million.

Operating Cash Flow	30.59M
Capital Expenditures	-13.26M
Free Cash Flow	17.33M
FCF Per Share	0.03

Margins

Gross margin is 21.64%, with operating and profit margins of 1.67% and 0.02%.

Gross Margin	21.64%
Operating Margin	1.67%
Pretax Margin	1.55%
Profit Margin	0.02%
EBITDA Margin	2.52%
EBIT Margin	1.67%
FCF Margin	1.21%

Dividends & Yields

S.C. Ropharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	0.31%
FCF Yield	19.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

S.C. Ropharma has an Altman Z-Score of 1.85 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.85
Piotroski F-Score	6